Possibly for control of symptoms. But not cure ( similarly not a cure for cancer). That I think can be a market for cannaboid product ( of which there are many many many companies out there, NOT just MXC)
Only phase 2 trials.
https://clinicaltrials.gov/ct2/show/NCT01776970?recrs=ae&cond=ALS&cntry=IT&draw=1
Unlikely to get to phase 3 trial. The numbers will be too small.
Hint of events to follow, page-142
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.025(7.94%) |
Mkt cap ! $13.13M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 29.0¢ | $688 | 2.372K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1033 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 11.01am 03/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |